Bacterial meningitis is an infection of the membranes surrounding the brain and spinal cord, called the meninges. It is a medical emergency. Even with treatment in high-income countries, roughly 14% of patients die, and the risk of death more than doubles when antibiotics are delayed beyond two hours of hospital arrival. Surviving it often means facing lasting neurological effects.
How Bacteria Reach the Brain
The brain is protected by a tightly sealed network of blood vessels called the blood-brain barrier. Only a handful of bacterial species can breach it. The most common route is through the bloodstream: bacteria from an infection elsewhere in the body multiply, circulate in the blood, and cross into the fluid surrounding the brain and spinal cord. The two species best equipped to do this are the ones that cause most cases in older children and adults.
Bacteria can also reach the meninges through other paths. A severe ear infection or sinus infection can spread directly into the central nervous system. Skull fractures, congenital defects in the membrane covering the brain, or neurosurgical procedures can create openings that let bacteria in.
Once bacteria invade the fluid around the brain, components of their cell walls trigger the brain’s immune cells to launch an intense inflammatory response. That inflammation makes the tiny blood vessels in the brain leaky, causing widespread swelling. The swelling raises pressure inside the skull, which is what drives many of the most dangerous symptoms and complications.
Which Bacteria Cause It
The likely culprit depends heavily on age. In newborns and very young infants, the most common causes are group B strep (often passed from the mother during birth), E. coli, and Listeria. In older children, teenagers, and young adults, two species dominate: meningococcus and pneumococcus. Meningococcus is the one responsible for the outbreaks that sometimes sweep through college dormitories or military barracks.
In middle-aged and older adults, pneumococcus becomes the leading cause, with Listeria re-emerging as a significant threat in people over 60 and those with weakened immune systems. Staph bacteria can cause severe meningitis at any age, particularly after a penetrating head wound.
Symptoms and How They Develop
The classic signs are fever, a stiff and painful neck, and altered mental status, ranging from confusion to drowsiness to unresponsiveness. Not everyone develops all three at once, which is part of what makes early diagnosis tricky. Symptoms often come on fast, progressing from feeling generally unwell to seriously ill within hours.
Other common symptoms include a severe headache that feels different from a typical headache, sensitivity to light, nausea and vomiting, and sometimes seizures. In meningococcal meningitis specifically, a distinctive rash can appear: small, dark red or purple spots that don’t fade when you press a glass against them. This rash signals that bacteria are damaging blood vessels under the skin and is a reason to seek emergency care immediately.
In newborns and young infants, the signs are harder to spot. Babies may be unusually irritable or lethargic, feed poorly, have a bulging soft spot on the head, or simply seem “not right” without the classic stiff neck that older patients develop.
How It Is Diagnosed
The definitive test is a lumbar puncture, sometimes called a spinal tap. A needle is inserted into the lower back to collect a small sample of the cerebrospinal fluid that bathes the brain and spinal cord. In bacterial meningitis, that fluid typically shows a surge of white blood cells (particularly the type that fights bacterial infections), elevated protein levels, and glucose levels that drop below 50% of the blood sugar measured at the same time. Bacteria are often visible under a microscope or grow in lab cultures from the fluid sample.
Doctors also draw blood for cultures and may order brain imaging before the lumbar puncture if there are signs of severely elevated brain pressure. Critically, the diagnostic workup should not delay antibiotic treatment. If bacterial meningitis is suspected, antibiotics are started before test results come back.
Why Speed of Treatment Matters
Bacterial meningitis is one of the most time-sensitive infections in medicine. A multinational study found that when antibiotics were given more than two hours after hospital arrival, the odds of dying increased 2.3-fold. Delays beyond three hours were also linked to a 1.8-fold increase in the likelihood of lasting neurological damage.
Treatment begins with intravenous antibiotics, typically a broad-spectrum type that covers the most probable bacteria before lab results confirm the exact species. For patients over 60, pregnant, or immunocompromised, an additional antibiotic is added to cover Listeria, which doesn’t respond to the standard first-line drugs. In some cases, a steroid medication is given alongside the antibiotics to help dampen the inflammatory swelling in the brain, reducing the risk of death and neurological complications.
Long-Term Effects in Survivors
Surviving bacterial meningitis does not always mean a full recovery. Overall, about one in five survivors leaves the hospital with at least one lasting complication. The risk varies by the type of bacteria involved. Pneumococcal meningitis carries the highest burden: roughly 25% of survivors develop a major long-term problem. For meningococcal meningitis, the rate is closer to 7%.
Hearing loss is the single most common lasting effect, accounting for about a third of all major complications. It can range from partial loss in one ear to complete deafness, and it sometimes isn’t detected until weeks or months after discharge. Other major complications include cognitive difficulties (problems with memory, attention, or learning), motor impairments, recurring seizures, vision problems, and hydrocephalus, a buildup of fluid in the brain that may require surgical drainage. About 20% of those with complications have more than one.
Children who survive bacterial meningitis are often monitored with hearing tests and developmental assessments in the months and years that follow, because some deficits only become apparent as a child grows and faces new cognitive demands in school.
Vaccines That Prevent It
Vaccination has dramatically reduced bacterial meningitis in countries with widespread immunization programs. Several vaccines target the most common culprits.
- MenACWY vaccine: Protects against four strains of meningococcus. The CDC recommends a first dose at age 11 to 12, with a booster at 16 because protection fades over time. If the first dose was given between 13 and 15, the booster is recommended between 16 and 18.
- MenB vaccine: Covers a fifth strain of meningococcus (serogroup B). This one is not routinely recommended for all teens. Instead, the CDC suggests a shared decision between the patient and their doctor, typically for those aged 16 to 23. The standard schedule is two doses six months apart, though a three-dose accelerated schedule is available for people who need faster protection, like students about to start college.
- Pneumococcal vaccine: Protects against pneumococcus, the leading cause of bacterial meningitis in adults. It is part of the routine childhood vaccine schedule and is also recommended for adults over 65 and those with certain medical conditions.
- Hib vaccine: Targets Haemophilus influenzae type b, which used to be a major cause of meningitis in young children. Widespread vaccination has made Hib meningitis rare in developed countries, though it persists where the vaccine is less available.
What Happens After Exposure
Close contacts of someone diagnosed with meningococcal meningitis are offered preventive antibiotics, because the bacteria spread through respiratory droplets and saliva. “Close contact” typically means household members, romantic partners, or anyone who shared prolonged face-to-face proximity. Brief, casual contact like passing someone in a hallway does not qualify.
The standard preventive antibiotics have traditionally included ciprofloxacin, rifampin, or ceftriaxone. However, the CDC updated its guidance in 2024 in response to rising ciprofloxacin resistance. In areas where 20% or more of meningococcal cases involve ciprofloxacin-resistant strains, health departments now recommend using rifampin, ceftriaxone, or azithromycin instead. Preventive treatment is most effective when given as soon as possible after the exposure is identified.